/Investor DB

Trans-Pacific Technology Fund — Full Portfolio

13 tracked investments · listed companies and verified rows first

Ginkgo Bioworksginkgo.bioin𝕏NYSE: DNA

Ginkgo Bioworks builds autonomous labs that accelerate bioengineering for applications in pharmaceutical, agricultural, and industrial biotechnology.

AgTechAI & Machine LearningBiotechDeep TechHealthtechRoboticsBoston, US

Jason Kelly(Founder)inReshma Shetty(Founder)inBarry Canton(Founder)inAustin Che(Founder)inTom Knight(Founder)inBartholomew Canton(Executive Officer)

Co-investors11.2 CapitalAllen Institute for AI (AI2) IncubatorAzure Capital PartnersB3 HoldingBlue Owl CapitalCannage Capital+62 more

Pyxis Oncologypyxisoncology.comin𝕏NASDAQ: PYXS

Pyxis Oncology develops antibody-drug conjugates and immunotherapies targeting difficult-to-treat cancers to improve patient outcomes.

BiotechDigital HealthHealthtechMedical DevicesBoston, US

Thomas Civik(Interim Chief Executive Officer, Director)

BoardDavid Steinberg(Executive Officer, Director)inChristoph Westphal(Director)Geeta Vemuri(Director)inJak Knowles(Director)John Flavin(Director)

Co-investorsAgent CapitalLifeSci Venture PartnersLongwood FundPfizer Venture InvestmentsRA CapitalRTW Investments L.P.

Bened Biomedicalbenedbiomed.com

Bened Biomedical develops probiotic products focused on neurological health, serving customers across more than 40 markets worldwide through regionally located manufacturing partners.

BiotechHealthtechWellness & FitnessTaipei, TW

Crown BioSciencecrownbio.comin𝕏

Crown Bioscience is a contract research organization based in California providing discovery, preclinical, and translational platforms and services for oncology and immuno-oncology drug development.

BiotechHealthtechMedical DevicesCalifornia, US

Co-investorsAcorn Pacific VenturesGRC SinogreenLAVLilly Asia VenturesQiming Venture Partners

Finch Therapeuticsfinchtherapeutics.comin𝕏Feb 2018

Finch Therapeutics is a life sciences company focused on the development and protection of drug-related intellectual property and therapeutics within the biotechnology and pharmaceutical industry.

BiotechHealthtechMedical DevicesSomerville, US

Mark Smith(Executive Officer, Director)inMatt Blischak(Chief Executive Officer)inR. J. Price(Director)Jeffery A. Smisek(Director)Andrew Mulderry(Director)James Burgess(Director)

Co-investorsAvenir Growth CapitalB3 HoldingKleinmuntz AssociatesOctave Ventures LlcOCV PartnersOMX Ventures+2 more

Katakata.aiin𝕏Aug 2017

Kata.ai provides a large language model that lets brands and enterprises build intelligent chatbots for marketing, commerce, and behavioral data collection across social and chat apps such as LINE, Facebook, and WhatsApp.

AI & Machine LearningE-commerceEnterprise SoftwareHR TechMarketing TechSaaSSales Tech

Ahmad Rizqi Meydiarso(Founder)inChristian FrankeIrzan Raditya(Founder)inReynir Fauzan(Founder)inWahyu Wrehasnaya(Founder)in

Co-investors500 GlobalAC VenturesRed Sails InvestmentSpiral VenturesConvergence VenturesMDI Ventures

Rancher Labsrancher.comin𝕏

Rancher is an open-source container management platform that provides enterprise-grade Kubernetes orchestration and management across data centers, clouds, and edge environments.

Cloud ComputingDeveloper ToolsEnterprise Software

Sheng Liang(Founder)inDarren Shepherd(Founder)Shannon Williams(Founder)Will Chan(Founder)

Co-investorsGRC SinogreenMayfield FundTitanium VenturesNexus Venture Partners

Reyrey.idin𝕏

Rey.id addresses inefficiencies in the healthcare industry through solutions targeting health service provision, fraud prevention, and chronic disease management.

Digital HealthHealthtechInsurTech

Co-investorsGenesia Ventures

Other

Tracked investments with no reachable website or further public details — typically companies that wound down, renamed, or were absorbed.

Applied BioCodeGet HealGoogol TechnologyHealMegaPro Therapeutics

Rows marked “SEC filing” are inferred from directors named on the company's SEC Form D — public regulatory data, not a portfolio list published by the firm.